Genetic mutation that may alter response to cancer therapeutics found

[Joe]

Researchers from Eli Lilly & Company and the Phoenix-based Translational Genomics Research Institute (TGen) today announced finding a novel recurring mutation of the gene AKT1 in breast, colorectal and ovarian cancers.

More... (http://www.news-medical.net/?id=27144)